Science born out of Genzyme underpins new cystic-fibrosis startup
Sionna Therapeutics, a cystic fibrosis –focused company advancing science that dates back to storied biotech Genzyme, has launched and revealed $150 million in funding.
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Rowan Walrath Source Type: news
More News: Biotechnology | Cystic Fibrosis | Funding | Health Management | Pharmaceuticals | Science